« Previous
Next »
American Journal of Cardiology
Volume 106, Issue 3
, Pages 297-304
, 1 August 2010
Relation of Body Mass Index to Mortality Among Men With Coronary Heart Disease
References
- . Rationale and design of a secondary prevention trial of increasing serum HDL cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease. Am J Cardiol. 1993;71:909–915
- . Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease: the Bezafibrate Infarction Prevention (BIP) study. Circulation. 2000;102:21–27
- . K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1–S266
- . Tutorial in biostatistics: multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361–387
- . Body mass index and mortality: a meta-analysis based on person-level data from twenty-six observational studies. Ann Epidemiol. 2005;15:87–97
- . Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373:1083–1096
- . The syndrome of cardiac cachexia. Int J Cardiol. 2002;85:51–66
- . Guidelines for healthy weight. N Engl J Med. 1999;341:427–434
- . The obesity paradox in patients with peripheral arterial disease: the influence of chronic obstructive pulmonary disease. Chest. 2008;134:925–930
- . Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet. 2006;368:666–678
- . Relation of body mass index to outcome in patients with known or suspected coronary artery disease. Am J Cardiol. 2007;99:1485–1490
- . The influence of body mass index on mortality and bleeding among patients with or at high-risk of atherothrombotic disease. Eur Heart J. 2009;30:857–865
- . Impact of the body mass index on occurrence and outcome of acute ST-elevation myocardial infarction. Clin Res Cardiol. 2008;97:83–88
- . Excess weight at time of presentation of myocardial infarction is associated with lower initial mortality risks but higher long-term risks including recurrent re-infarction and cardiac death. Int J Cardiol. 2006;110:153–159
- . The impact of body mass index on short- and long-term outcomes in patients undergoing coronary revascularization (Insights from the Bypass Angioplasty Revascularization Investigation (BARI)). J Am Coll Cardiol. 2002;39:834–840
- . Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ Res. 2004;94:223–229
- . Relation between obesity and severity of coronary artery disease in patients undergoing coronary angiography. Am J Cardiol. 2006;97:1277–1280
- . Medical therapies and invasive treatments for coronary artery disease by body mass: the “obesity paradox” in the Get With the Guidelines database. Am J Cardiol. 2007;100:1331–1335
- . The obesity paradox: fact or fiction?. Am J Cardiol. 2006;98:944–948
- . Weight-change as a prognostic marker in 12 550 patients following acute myocardial infarction or with stable coronary artery disease. Eur Heart J. 2006;27:2755–2762
- . Weight change after myocardial infarction—the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) experience. Am Heart J. 2008;155:478–484
- . Association of intentional changes in body weight with coronary heart disease event rates in overweight subjects who have an additional coronary risk factor. Am J Epidemiol. 2005;161:352–358
- . Effects of cardiac rehabilitation, exercise training, and weight reduction on exercise capacity, coronary risk factors, behavioral characteristics, and quality of life in obese coronary patients. Am J Cardiol. 1997;79:397–401
- . Voluntary and involuntary weight loss: associations with long term mortality in 9,228 middle-aged and elderly men. Am J Epidemiol. 1998;148:546–555
- . Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet. 2005;366:1640–1649
PII: S0002-9149(10)00941-0
doi: 10.1016/j.amjcard.2010.03.078
© 2010 Elsevier Inc. All rights reserved.
« Previous
Next »
American Journal of Cardiology
Volume 106, Issue 3
, Pages 297-304
, 1 August 2010
